drugset / Trial / NCT01753362
Liraglutide In Overweight Patients With Type 1 Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to examine the effects of liraglutide (a drug used to treat type 2 diabetes) on glucose (sugar) control over the 26 week study period when used in addition to insulin.
Timeline
- Start
- 2012-12
- Primary completion
- 2017-12
- Completion
- 2018-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Liraglutide | Peptide | — | Subcutaneous |